Discovery of investigational drug CT1812, an antagonist of the Sigma-2 receptor complex for Alzheimers disease
M., Fayez, A
Novo Nordisk, the global pharmaceutical company behind the popular weight-loss medication Wegovy, has filed 14 additional lawsuits against pharmacies producing compounded versions of semaglutide, the active ingredient in the drug
Safety with Travel or Extended Storage Planning to travel or store the medication for an extended period
It increases the risk of: Type 2 diabetes MASLD (metabolic dysfunction-associated steatotic liver disease, formerly called NAFLD) Cardiovascular disease The loss of estrogen also accelerates sarcopenia, the loss of lean muscle mass, which further slows metabolism and reduces energy expenditure
Available in both injection and tablet forms, it offers flexibility and convenience for individuals looking to incorporate medical support into their health routine